Day: June 27, 2024

NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) — Getty Realty Corp. (NYSE: GTY) will release its financial results for the second quarter ended June 30, 2024, after the market closes on Wednesday, July 24, 2024. Getty Realty Corp. will host a conference call and webcast on Thursday, July 25, 2024, at 8:30 a.m. EDT. To participate in the call, please dial 1-877-423-9813, or 1-201-689-8573 for international participants, ten minutes before the scheduled start. Participants may also access the call via live webcast by visiting the investors section of the Company’s website at ir.gettyrealty.com. If you cannot participate in the live event, a replay will be available on Thursday, July 25, 2024, beginning at 11:30 a.m. EDT through 11:59 p.m. EDT, Thursday, August 1, 2024. To access the replay, please dial 1-844-512-2921, or 1-412-317-6671...

Additional $6.7M in funding resulting in approximately $67M in gross proceeds NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced that the underwriters of its previously announced public offering, which closed on June 24, 2024, have exercised an over-allotment option to purchase an additional 1,786,589 shares of the Company’s common stock at the public offering price of $4.00 per share, less underwriting discounts and commissions. After giving effect to the option closing, the total number of shares sold by the Company in the offering were 13,036,589 shares, which along with pre-funded warrants to purchase up to an aggregate of 3,750,000 shares...

Partnership Leverages Extensive Pipeline Inspection Data to Enhance Service Offerings and Strategic Positioning in Water Environmental Protection Market SHENZHEN, China, June 27, 2024 (GLOBE NEWSWIRE) — CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (“CDT”), a leading provider of waste treatment systems and services throughout China, announces the signing of a strategic cooperation framework agreement with a local high-tech company in Fujian Province. The collaboration leverages the complementary strengths of both parties, with CDT contributing its government relations, brand advantages, and expertise in waste treatment solutions, while the partner contributes its local experience and crucial pipeline inspection data. The result is anticipated to be a greatly enhanced service platform, with...

Shares Expected to Begin Trading on Split-Adjusted Basis on July 1, 2024 SAN DIEGO, June 27, 2024 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today announced that it will implement a 1-for-12 reverse split of the issued shares of its common stock, effective at 12:01 a.m. Eastern Time on July 1, 2024. The Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on Monday, July 1, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol “DARE.” The new CUSIP number for the common stock will be 23666P200. The reverse stock split is intended to increase the bid price of the common stock to enable the Company to regain compliance with the $1.00 minimum bid price requirement for continued listing...

DALLAS, June 27, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has surpassed 90% of the enrollment target for pediatric patients at burn centers for its 2024 pivotal study designed to validate the AI-driven algorithm used by its DeepView™ System for its burn indication. “We are excited with the progress on enrollment of pediatric subjects, which has exceeded our expectations given the difficulties normally experienced in trials for this age group,” said Peter M. Carlson, CEO of Spectral AI. “We continue to enroll adult and pediatric subjects at both burn centers and emergency departments for our 2024 pivotal study.” This...

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) — Mink Ventures Corporation (TSXV:MINK) (“Mink” or the “Company“) today announced it has commenced the summer exploration program at its Warren nickel copper cobalt project, located approximately 35 km southwest of Timmins, Ontario. The exploration program involves prospecting work to evaluate a series of high priority Ni Cu zones, followed by diamond drilling. These fully funded programs will enable Mink to complete the work component of its option to earn a 100% interest in the project. “We are pleased to kick off this exploration program at such a prospective project for nickel, copper, and cobalt. The Warren project is further enhanced by its enviable access to the skilled labour, green power, and infrastructure of the emerging Timmins Nickel Camp. Exploration stage companies...

ALMATY, Kazakhstan, June 27, 2024 (GLOBE NEWSWIRE) — Kaspi.kz (KSPI US) will report its financial results for the quarter and first half ended June 30, 2024, on Monday, 22 July, 2024. On that day, management will hold a conference call and webcast at 8.00am EST (1pm GMT, 5.00pm Astana time) to review and discuss the company’s results for the period. 2nd Quarter & First Half 2024 Financial Results Conference Call Monday, 22nd July, 2024 To pre-register for this call, please go to the following link: https://www.netroadshow.com/events/login?show=003831c9&confId=67819 You will receive your access details via email. About Kaspi.kz Kaspi.kz’s mission is to improve people’s lives by developing innovative mobile products and services. To deliver upon this we operate a unique two-sided Super App model – Kaspi.kz Super...

New private label dried fruit products expected to enter 3,430 stores in 2024 BEND, Ore., June 27, 2024 (GLOBE NEWSWIRE) — BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that the nation’s largest retailer has increased the store count and overall projected sales of its third contract with BranchOut Food. The new third contract now has a value of approximately $1 million in sales and is three times larger than the retailer’s original projection. The retailer will offer the private label products in 3,430 stores across the nation, up from an original store count of 1,400. “We are excited about the rapid pace of adoption and popularity of BranchOut Food’s products, and very pleased to be increasing our private label offering with...

TAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) — TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced today that with the filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), the Company regained compliance with Nasdaq listing rules and posted net income of over $21 million for the period in question due to the previously announced sale of substantially all of the assets of the Company’s wholly-owned subsidiary Trxade, Inc. On May 23, 2024, the Company received a standard notice of noncompliance from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that, as a result of not having timely filed its Form 10-Q for the first quarter of 2024, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial...

“One of the very few companies globally to achieve these certifications” VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The Company”, a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce that it has been granted a Drug Establishment License (DEL) by Health Canada. This license allows HYTN to engage in the GMP fabrication, packaging, and labeling of non-sterile pharmaceuticals containing both cannabis and psilocybin, significantly enhancing the Company’s capabilities and expanding its market reach. With this license, HYTN is now positioned to manufacture and export these pharmaceutical products into regulated global...